- Side effects include unfavorable symptoms or conditions and laboratory results outside of normal range that occur or worsen because of a treatment
- After 9 months of treatment with AMVUTTRA™, the most common side effects were joint pain (11%), shortness of breath (7%), and low vitamin A levels (7%)
- Injection site reactions were mild in severity, decreased over time, and occurred in 5 patients (4%) during the clinical study
- Another type of unfavorable symptoms or conditions and abnormal laboratory results that can occur while taking a medication is called an adverse event. Unlike side effects, it is unknown whether adverse events are caused by the treatment
- After 18 months of treatment with AMVUTTRA, reported adverse events included pain in a limb (such as the arm or leg), joint pain, abdominal pain, low vitamin A levels, shortness of breath, and troponin T increased (a laboratory test result)
Talk to your doctor if you have any questions about treatment with AMVUTTRA.